Legend Biotech Corporation (LEGN)

NASDAQ

$22.00

-$0.32 (1.43%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$21.80$22.61

Open $22.59

52 Week Range

$21.80$45.30

Previous Close $22.32

Market Cap2.01B

Volume2.81M

Avg Volume1.71M

P/E (TTM)-6.16

EPS (TTM)$-3.54

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Legend Biotech Corporation

DEC62025

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

Source: GlobeNewsWire•9 days ago

SOMERSET, N.J., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced new long-term clinical and translational data for CARVYKTI® (ciltacabtagene autoleucel; cil...

NOV132025

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Source: GlobeNewsWire•32 days ago

31,000-square-foot site expands Legend's U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation...

NOV32025

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Source: GlobeNewsWire•42 days ago

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session SOMERSET, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- ...

OCT292025

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

Source: GlobeNewsWire•47 days ago

SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third qu...